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A dataset of 103 SARS-CoV isolates (101 human patients and 2 palm civets) was
investigated on different aspects of genome polymorphism and isolate classification.
The number and the distribution of single nucleotide variations (SNVs) and inser-
tions and deletions, with respect to a "profile", were determined and discussed
("profile" being a sequence containing the most represented letter per position).
Distribution of substitution categories per codon positions, as well as synonymous
and non-synonymous substitutions in coding regions of annotated isolates, was de-
termined, along with amino acid (a.a.) property changes. Similar analysis was
performed for the spike (S) protein in all the isolates (55 of them being predicted
for the first time). The ratio Ka/Ks confirmed that the S gene was subjected to the
Darwinian selection during virus transmission from animals to humans. Isolates
from the dataset were classified according to genome polymorphism and geno-
types. Genome polymorphism yields to two groups, one with a small number of
SNVs and another with a large number of SNVs, with up to four subgroups with
respect to insertions and deletions. We identified three basic nine-locus genotypes:
TTTT/TTCGG, CGCC/TTCAT, and TGCC/TTCGT, with four subgenotypes.
Both classifications proposed are in accordance with the new insights into possible
epidemiological spread, both in space and time.
Key words: SARS Coronavirus, single nucleotide polymorphism, insertions, deletions, spike
protein, phylogenesis
Introduction
Severe acute respiratory syndrome (SARS), poten-
tially fatal atypical pneumonia, first appeared in
Guangdong province of China in November 2002 and
soon afterward, within six months, spreaded all over
the world (30 countries including China, Singapore,
Vietnam, Canada, and USA), killing more than 700
people (1). In less than four weeks after the global
outbreak, a novel member of Coronaviridae family,
namely SARS Coronavirus (SARS-CoV), was identi-
fied in the blood of respiratory specimens and stools
of SARS patients, and confirmed as the causative
agent of disease according to the Koch postulates (2).
Soon afterwards, first fully sequenced genomes of vi-
ral isolates were published (3 ,4) . In 2005 the number
of fully sequenced viral isolates exceeds one hundred
(http://www.ncbi.nlm.nih.gov/entrez).
SARS-CoV probably originated due to genetic ex-
change (recombination) and/or mutations between
viruses with different host specificities (5, 6). Since
coronaviruses are known to relatively easily jump
among species, it was hypothesized that the new virus
might have originated from wild animals. The analy-
sis of SARS-CoV proteins supports and suggests pos-
sible past recombination event between mammalian-
like and avian-like parent viruses (6). Common se-
quence variants define three distinct genotypes of
the SARS-CoV: one linked with animal [palm civet
(Paguma larvata)] SARS-like viruses and early hu-
man phase, the other two linked with middle and late
human phases, respectively (7,8). SARS-CoV has
a deleterious mutation of 29 nucleotides relative to
the palm civet virus, indicating that if there was di-
rect transmission, it went from civet to human, be-
cause deletions occur probably more easily than in-
sertions (5). However, more recent reports indicate* Corresponding author.E-mail: gordana@matf.bg.ac.yu
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that SARS-CoV is distinct from the civet virus and
it has not been answered so far whether the SARS-
CoV originated from civet, or civet was infected from
other species (9,10). The genome is relatively stable,
since its mutation rate has been determined to be be-
tween 1.83×10-6 and 8.26×10-6 nucleotide substitu-
tions per site per day (11).
The SARS-CoV genome is approximately 30 Kb
positive single strand RNA that corresponds to poly-
cistronic mRNA, consisting of 5' and 3' untrans-
lated regions (UTRs), 13 to 15 open reading frames
(ORFs), and about 10 intergenic regions (IGRs)
(9,12,13). Its genome includes genes encoding
two replicate polyproteins (RNA-dependant-RNA-
polymerase, i.e., pp 1a and pp 1ab), encompass-
ing two-thirds of the genome, and a set of ORFs
at 3' end that code for four structural proteins:
surface spike (S) glycoprotein (1,256 a.a.), enve-
lope (E, 77 a.a.), matrix (M, 222 a.a.), and nucle-
ocapsid (N, 423 a.a.) proteins. It also encodes
for additional 8-9 predicted ORFs whose protein
product functions are still under investigation (14;
http://www.ncbi.nlm.nih.gov/entrez).
The S protein is the main surface antigen of the
SARS-CoV and is involved in virus attachment on
susceptible cells using mechanism similar to those of
class I fusion proteins. The receptor for the SARS-
CoV S protein is identified as angiotensin-converting
enzyme 2 (ACE-2), which is a metallopeptidase (15).
The receptor-binding domain (RBD) has been deter-
mined to lay between a.a. postions 270-625 in recent
studies (16-20).
Several epitope sites, defined by polyclonal or
monoclonal antibodies, have been identified on the
S protein, depending on experimental conditions, all
lying within wide or narrow regions between a.a. 12-
1,192 (20-31). Defining conserved immunodominant
epitope regions of the S protein is of crucial impor-
tance for future anti-SARS vaccine development.
The main goal of this work was twofold: to per-
form mutation analysis of SARS-CoV viral genomes,
with special attention to the S protein; and to group
them according to different aspects of sequence simi-
larity, eventually pointing to phylogeny and epidemi-
ological dynamics of SARS-CoV.
Results and Discussion
Nucleotide content
Nucleotide content of SARS-CoV isolates favors T
and A nucleotides. The corresponding percentages
of letters in non-UTR regions of all the 96 iso-
lates were found to be as follows: T (30.7940%),
A (28.4246%), G (20.8121%), C (19.9535%), N (G,
A, T, C; 0.0143%), R (Pur; 0.0005%), K (G or T;
0.0001%), M (A or C; 0.0002%), S (G or C; 0.0001%),
W (A or T; 0.0002%), and Y (Pyr; 0.0004%). The
overall ratio of (A,T)/(G,C) in the dataset was almost
3:2 (1.45). The ratio of Pur vs. Pyr nucleotides was
almost 1 (0.97).
The distribution of nucleotides (nt) over sequences
of length 250 nt is given in Figure S1 (Supporting
Online Material). It exhibits three peak-regions of
T nucleotide in the second quarter of the genome
(ORF 1a), and rather stable behavior in the third
quarter of the genome (ORF 1b), as also observed by
Pyrc et al (32) for a group of coronaviruses (HCoV-
NL63, HCoV-229E, SARS-CoV, and HCoV-OC43).
Deviation of percentage of nucleotides over 250-nt
blocks from the corresponding percentage in the whole
dataset is given in Figure S2. Except for 3' UTR
where T nucleotide is underrepresented with even
about —13%, the highest excess from the average is
about +10% in four peaks, which is exhibited again by
T nucleotide, three of them being between positions
7,000 and 11,000 (ORF 1a), complementary with the
nucleotide A represented with —10%, and the fourth
one in the S protein. Otherwise the nucleotides' off-
set oscillates rather regularly between —5% and +5%
from the average.
Genome polymorphism
All the isolates had high degree of nucleotide iden-
tity (more than 99% pair wise). Still, they could be
differentiated on the basis of their genome polymor-
phism, i.e., the number and sites of SNVs and inser-
tions and deletions (INDELs). Analysis of genomic
polymorphism of the isolates resulted in the following
two facts (Tables 1, S1, and S2). Firstly, two isolates,
HSR 1 and AS, coincided with the "profile" on all
the "non-empty" positions (see Materials and Meth-
ods) up to the poly-A sequence. Secondly, three iso-
lates had large number of undefined nucleotides (N),
either as contiguous segments (Sin3408 in ORFs 8a,
8b; Sin3408L in ORF 1b), or as scattered individual
nucleotides or short clusters (SinP2) (Table S2). Iso-
late Sin3408 was the only one that has a 34-nt longer
5' UTR as compared with the "profile". Thus these
three isolates were not considered to be reliably com-
pared with others.
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Shaded entries correspond to annotated isolates. Identification (Label and ID) is given in accordance with the labels
and identifiers from Table S1. The four SNVs columns correspond to: the total number of SNVs, the number of SNVs
in genes, in 5' and 3' UTRs, and in IGR. The seven columns named INDELs include the number of deletions at the
5' end (5' del), the length of long insertions (longIns) and long deletions (longDel), the number and length of short
insertions (shortIns) and short deletions (shortDel) in the form a × b where b denotes the length and a denotes the
number of occurrences, the number of deletions at the 3' end (3' del), and the length of a poly-A sequence at the 3' end
(3' poly-A). Classification includes two columns. The Type column corresponds to the nine-locus nucleotides that
are given in the form NNNN/NNNNN and represent nucleotides at (relative to CLUSTAL X output) positions 9,420,
17,604, 222,274, 27,891 / 3,861, 9,495, 11,514, 21,773, 26,534, respectively (absolute HSR 1 positions 9,404, 17,564,
22,222, 27,827 / 3,852, 9,479, 11,493, 21,721, 26,477). The last column, Group, reflects grouping of isolates.
Nucleotide variations: single nucleotide poly-
morphism
There were 446 SNV sites and 1,006 SNVs in to-
tal in the dataset, with the substitution rate 1.49%,
which is about three times higher (both the number of
SNVs and the substitution rate) than the correspond-
ing findings (33) for 17 isolates. An average number
of SNVs per isolate was 10.48, giving an error rate of
3.6×10-4 substitutions per nucleotide copied.
There was only one site with multiple base substi-
tutions (the original nucleotide base on that position
being T): at the relative (CLUSTAL X) position 8,441
(ORF 1a), isolate ZMY 1 has the nucleotide C (ab-
solute position 8,403), and isolates ShanghaiQXC1,
ShanghaiQXC2 have the nucleotide A (absolute posi-
tions 8,312 and 7,733, respectively).
The smallest distance between the two neighbor-
ing SNV sites in the whole dataset was 1; the largest
one was 23,988 (in case of TW3 and TW1), while an
average distance between the neighboring SNV sites
in the whole dataset was 1,987 positions (Figure S3).
The distribution of isolates per SNV number (outside
5', 3' UTRs) showed regularity for up to 11 SNVs (al-
most Gaussian distribution) and irregular decrease for
number of SNVs >11 (Figure S4). Thus the number
of SNVs less than or equal to 11 per isolate was con-
sidered as a "small" number of SNVs, and the number
of SNVs greater than 11 was considered as a "large"
number of SNVs. Most SNVs are clustered within
two regions in ORF la and one region at the 3' end of
the viral genome that predominantly consists of small
ORFs, leaving two small regions within ORF 1a, and
a region that corresponds to ORF 1b as the most con-
servative ones (Figure 1B).
The entropy of each genome nucleotide position
was calculated, showing that the most conserved sites
are the ones with the smallest entropy and that the
least conserved sites are the ones with the highest en-
tropy (34; Figure S5). The nine loci used for classifi-
cation can be found among the sites with the highest
entropy.
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Fig. 1 Density distribution of SNVs (B), INDELs (C), mapped onto the gene map of the HSR 1 isolate, coinciding
with the "profile" (A). Central region of the genome is rather conserved (lower density of SNVs is exhibited in the
second third of the genome, ORF 1b), while the rest of the genome features high SNVs density. SNV peaks are present
at (absolute HSR 1) positions 3,852, 9,404, 9,479, 11,493, 17,564 (ORF lab), 21,721, 22,222 (S protein), 26,477 (M
protein), and 27,827 (ORF 8a).
Percent of each category of substitution is given
in Figure 2. There are 141 transversion sites and
306 transition sites, i.e., 31.54%:68.46%, with 261
transversions (2.72 in average per isolate) and 745
transitions (7.76 in average per isolate).
Length variations, insertions and deletions
Analysis of the SARS-CoV genome showed that long
INDELs were concentrated close to the 3' end (except
for the 579-nt deletion in the ShanghaiQXC2 isolate
at the position 5,834, located in ORF 1a), while indi-
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Fig. 2 Distribution of nucleotide substitution categories. The most represented are the substitutions and the
least represented are the substitutions
vidual insertions were found along the whole genome,
most in the second quarter, and individual deletions
were quite rare. Density distribution of INDELs in-
side the SARS-CoV genome, and 5' UTR, 3' UTR
length variations, are represented in Figures 1C, S6A
and B, respectively. Figure S6C represents the region
of the genome between positions 27,700 and 28,300
(ORFs 7b, 8a, 8b, part of N-protein, in HSR 1 anno-
tation), which is especially abundant with INDELs.
While individual INDELs are present both in longer
and shorter ORFs, longer INDELs are (except for pre-
viously mentioned deletions in the ShanghaiQXC2) all
located in short ORFs.
Figure 3 represents comparison results of genome
primary structure of the analyzed isolates, summariz-
ing the following facts:
Firstly, although the SARS-CoV genome has the
established length of 29,727 nt (12), most isolates
were shorter at the 5' end (for the first 15 positions,
majority of isolates were "empty"), and had various
length "poly-A" strings at the 3' end, or both (Table
1). Several isolates had some short deletions inside
the sequence, e.g., Sin2677, Sin2748, TWC, PUMC02,
PUMC03, TWJ, WHU, Sino1-11, Sino3-11, TW11,
and SinP5.
Secondly, there was a group of isolates that had
insertions of length 29 nucleotides (GD01, SZ3, SZ16,
GZ02, HSZ-Bb, HSZ-Bc, HSZ-Cb, and HSZ-Cc) at
the relative position 27,995 (absolute position 27,869
in SZ3, SZ16, HSZ-Cc, and HSZ-Bc; protein BGI-
PUP GZ29-nt-Ins, ORF 8a). Two of them were iso-
lates from palm civet (SZ3 and SZ16) and the other
six were isolates from human patients. This specific
insertion is also treated as a deletion in all the other
isolates, evolved from this early group (10).
Thirdly, there were several groups of isolates that
had long deletions: GZ-B, GZ-C (length 39 at the
relative position 27,882, or absolute position 27,719
in GZ-C, ORF 7b), ZS-A, ZS-C (length 53 at the rel-
ative position 27,969, absolute 27,843 in ZS-A, ORF
8a), LC2, LC3, LC5 (length 386 at the relative po-
sition 27,829, absolute 27,704 in LC2, ORFs 7b, 8a,
8b), ShanghaiQXC2 (length 579 at the relative posi-
tion 5959, absolute 5834, ORF la), Sin852, Sin849,
and Sin846 (of length 57, 49, 137, respectively, at rel-
ative positions in region between 27,787 and 27,966,
ORFs 7b, 8a) (Tables 1 and S2, Figure 3).
Fourthly, a large number of individual INDELs
were identified in ZJ01, ZMY 1, SinP2, and SinP3
(Tables 1 and S2, Figure 3).
Mutation analysis
While the distribution of nucleotides over different
distances from SNV sites did not exhibit any regular-
ities, the distribution of different nucleotides on dis-
tance 1 left to SNV sites (-1) did exhibit significant
difference from their overall percentage in the dataset.
The corresponding right (+1) distance distribution of
nucleotides is almost uniform (Table 2).
Figure S7 represents differences between the per-
centage of nucleotides at a given position and in the
whole genome, for up to the distance 10 left and right
from SNV sites. Figures S8A and B represent dis-
tribution of substitutions preceded by different nu-
cleotide bases, and followed by different nucleotide
bases, respectively. It can be seen that on the
substitutions, both are favored by
the preceding A and the following T (almost 40% of
all the substitutions; Figure 2), while the sub-
stitution is almost prohibited by the preceding
T (only 3%). Clustered substitutions of length 2 are
rare
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Fig. 3 Comparison of nucleotide structures of SARS-CoV complete genome isolates, represented in parts A and B of
the figure according to similarity in their SNVs or INDELs positions.
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Table 2 Distribution of Nucleotides on Distance 1 Left and Right to SNV Sites
The distribution of nucleotides on distance 1 left to SNV sites (-1) and right to SNV sites (+1) is presented in total
number of nucleotides, percentage, and difference from their overall percentage in the dataset.
Codon usage
Analysis of distribution of individual nucleotides over
the three codon positions in annotated ORFs of all
the annotated isolates showed that, except for short
proteins such as E, M, and presumptive ORFs, all
the codons exhibit the same tendency of T nucleotide
dominating at the third codon position, and the G nu-
cleotide dominating at the first codon position, while
A and C appearing more often at the second codon
position than elsewhere. Figure S9 represents distri-
bution of nucleotides over the three codon positions
in individual ORFs, and in total.
Analysis of codon usage demonstrated the same
facts as the distribution of nucleotides over the three
codon positions. In total, the third nucleotide fa-
vored T (40.10%) over A (24.83%), C (18.90%), and G
(16.16%). It was especially true for four-codon fam-
ilies a.a. (Thr, Pro, Ala, Gly, and Val). The same
held for four-codon subsets of six-codon families (Arg,
Leu, and Ser), differring at the third codon position
only. The above was true for the ORF lab, S and N
proteins, but not for another two structural proteins
(E and M). The codon usage for SARS-CoV genome
proteins is represented by Table S3, and it is consis-
tent with the results obtained for another human CoV
genome, HCoV-NL63 (32).
Changes in amino acids
Besides the number of SNVs, isolates differed in
positions of SNVs, too. Table S4 represents po-
sitions where two or more SNVs occurred, for all
the annotated isolates, along with nucleotides and
ORFs (based on HSR 1 annotation), type of muta-
tion (transition/transversion), a.a. position in ORF,
a.a. change, a.a. property change, and nucleotide po-
sition in codon. Positions of multiple SNVs have been
chosen in order to reduce the chance of erroneously
determined SNV. There were 91 such SNV sites with
288 SNVs. It is interesting to notice that there were
no multiple base substitutions (more than two differ-
ent bases) in any of these positions. There were 227
transitions at 75 sites and 61 transversion at 16 sites,
out of which 5 were in structural proteins: 2 in S, 2
in E, and 1 in M proteins. The most common muta-
tion was mutation (45 sites or 50%), followed
by (30 sites), (7 sites each),
and (2 sites). There was no mutation of the
type
There were 28 SNV sites corresponding to the first
codon position (20 transitions and 8 transversions),
2 of which representing silent mutation sites
Leu). There were 33 SNV sites corresponding to the
second codon position (31 transitions and 2 transver-
sions), all of which cause a.a. change. There were
30 SNV sites corresponding to the third codon posi-
tion (25 transitions and 5 transversions), 29 of which
representing silent mutation sites (the only non-silent
one is
There were 31 synonymous multiple substitution
sites and 60 non-synonymous ones, with substitution
rate 0.31% (91/29,228) and non-synonymous substi-
tution rate 0.21%, which is consistent with the cor-
responding findings for 17 SASR-CoV isolates (33).
The number of multiple substitutions was for about
30% lower than the number of the overall substitu-
tions, and so were the substitution rate and non-
synonymous substitution rate.
Table S5 summarizes the above findings. It repre-
sents the number of transition and transversion sites
and the number of SNVs (in the form N1/N2) per po-
sition in codon and per mutation type, as well as the
percentage of SNVs, and the number of silent muta-
tion sites and silent SNVs.
Concerning non-synonymous sites, 35 are within
pp lab, 5 within ORF 3, 1 within E protein, 3 within
M protein, 1 within ORF 6, 1 within ORF 8a, 1 within
ORF 8b, 1 within N protein, and 11 within S protein
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(only for two-or-more substitution sites, and only in
annotated isolates).
Mutation analysis of the S protein
The S protein is of particular interest for mutation
analysis, being the key for host range determination.
Multiple sequence alignment of the S protein in all
the 96 SARS-CoV isolates showed that five of them,
namely ZMY 1, SinP2, SinP3, SinP4, and Sin3408L,
had large discrepancies with all the others due to indi-
vidual insertions or deletions in them. Since such sig-
nificant mismatches in the S protein sequence seemed
to be the result of erroneous sequencing, we elimi-
nated these five isolates and analyzed the S protein in
the remaining 91 isolates.
There were 34 isolates without SNVs in the S pro-
tein: TW2-TW11, Sino3-ll, AS, LC1, WHU, TWC3,
PUMC01-PUMC03, CUHK-AG01, CUHK-AG3, Tai-
wan TC1-3, TWC, Sin2748, Sin2500, Sin2677,
CUHK-Su10, HKU-39849, TWH, TWJ, TWK, TWY,
and HSR 1. There were 62 SNV sites with 208 SNVs
in total, and no multiple mutations. Table S6 rep-
resents SNV sites and all the SNVs in the S pro-
tein of the 91 isolates, along with nucleotides, type
of mutation (transition/transversion), a.a. position
in the protein, a.a. change, a.a. properties change,
nucleotide position in codon, and number of SNVs at
each SNV site. These findings overlap with the results
reported in Song et al (Ref. 7; concerning SNVs with
multiple occurrences, in 103 S protein genes, some of
which being nucleotide-identical, with 80% in com-
mon with our dataset), and are consistent on the in-
tersecting data. Table 3 summarizes the results from
Table S6.
Table 3 Mutation Analysis of the S Protein: Categories of Nucleotide Substitutions
S proteins in 91 isolates are considered. The number of transition and transversion sites and the number of SNVs (in
the form N1/N2) per position in codon and per mutation type, as well as the percentage of SNVs, and the number of
silent mutation sites and silent SNVs (in the form N1/N2), are presented.
Out of 62 SNV sites, 19 were observed to be syn-
onymous, with 58 synonymous SNVs in total, and
43 were observed to be non-synonymous substitution
sites, with 150 non-synonymous SNVs in total (Table
S6). Substitution rate was 1.65% (62/3,768) and non-
synonymous substitution rate was 1.14% (43/3,768),
which is consistent with findings for the whole genome
in the enlarged dataset, and is about three times
higher than the corresponding findings for 17 iso-
lates in Bi et al (Ref. 33; 22 substitution sites,
13 non-synonymous, substitution rates 0.58, 0.35, re-
spectively). As represented on Figure 4, most non-
synonymous a.a. substitutions are located in external
domain (ED); 14 of non-synonymous substitution are
in RBD, 3 of them in the most narrow intersecting
range. As it concerns epitopes, 40 of non-synonymous
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Fig. 4 Positions of synonymous and non-synonymous a.a. substitutions plotted against S protein primary structure.
The y-axis represents number of SNVs per positions. SP, signal peptide; ED, external domain; TM, trans-membrane
domain; and ID, internal domain (http://expasy.org/). A. RBD determined by: 1. Babcock et al (16), 2. Xiao et al
(17), 3. Wong et al (18), 4. Zhao et al (19), and 5. Zhou et al (20); B. epitope regions determined by: 1. Wang et
al (31), 2. Chou et al (29), 3. Greenough et al (30), 4. Sui et al (26), 5. van den Brink et al (28), 6. Lu et al (24),
7. Hua et al (23), 8. Ren et al (21), 9. He et al (22), 10. Zhou et al (20), 11. Zhang et al (27), and 12. Keng et al
(25).
a.a. substitutions are located in overall epitope do-
mains determined by various researchers. Finally, one
non-synonymous a.a. substitution is located in trans-
membrane domain (TM) and two in internal domain
(ID).
The coefficients Ks (number of synonymous sub-
stitutions per synonymous site) and Ka (number of
non-synonymous substitutions per non-synonymous
site) were calculated for all the 91 S proteins in the
dataset to be Ks = 0.00135, Ka = 0.00103, and the
ratio Ka/Ks had the value 0.7629 < 1, which may be
interpreted as evidence for the S protein not being
subjected to the Darwinian selection. These findings
are consistent with the similar analysis performed for
20 SARS-CoV isolates by Hu et al (35) giving the
ratio value of 0.65. Values of the corresponding coef-
ficients and the ratio Ka/Ks for the 89 human patient
isolates only, present even stronger evidence of the
S protein being subject to negative selection: Ks =
0.00121, Ka = 0.00080, Ka/Ks = 0.661. The coeffi-
cients Ka, Ks, and the Ka/Ks ratio for all the human
patients' isolates and each of the palm civet isolates as
the outgroup, are represented in Table 4. These values
indicated that the S gene was subjected to the Dar-
winian selection during virus evolution (transmission
from animals to humans), which is consistent with the
analysis performed by Yeh et al (36), for 28 human
isolates and the SZ3 palm civet as the outgroup, giv-
ing the corresponding ratio value of 1.657, and with
the analysis performed by He et al (8), indicating
that the S gene showed the strongest positive selec-
tion pressures initially, with eventual stabilization.
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Table 4 Mutation Analysis of the S Protein:
Coefficients Ka, Ks, and the Ratio Ka/Ks with
An Outgroup
Coefficients Ka, Ks are calculated for all the human pa-
tients' isolates and one of the palm civet isolates as an
outgroup.
Phylogenetic analysis
Phylogenetic tree, drawn using the PhyloDraw pro-
gram for the CLUSTAL X output of aligning the 96
isolates, is represented in Figure 5. Its close relation-
ship to the classification proposed in the paper sug-
gests that classification of SARS-CoV isolates might
be obtained by applying the computational analysis
based on genome polymorphism.
All the isolates were classified according to their
genome polymorphism—SNVs and INDELs, the pro-
cedure being proposed in our previous paper (57).
Since SNV contents turned out to be a more distin-
guishable property than the presence of INDELs, as
the first classification criterion we took the number
and positions of SNVs. For the "profile" isolate, as the
referent isolate, number of SNVs for different isolates
varied from 0 (HSR 1, AS) to 78 (ZMY 1) (Table 1).
All the isolates were classified into two groups based
on the number of SNVs with the "profile"—those with
less than or equal to 11 SNVs, and those having more
than 11 SNVs. Thus, the first classification criterion
resulted in two groups (Table 1):
Group A—isolates with less than or equal to 11
SNVs (Tables 1 and S2);
Group B—isolates with more than 11 SNVs rel-
ative to the "profile" isolate.
Positions of SNVs moved several isolates between
the two groups (SoD from B to A, since the most of its
SNVs are in 3' UTR; CUHK-W1 from A to B, since
its number of SNVs with the "profile" of the A group
is larger than the one of the B group; WHU from B to
A; GZ50 from A to B; GD69 from B to A; and GZ-C
from B to A).
The second classification criterion was presence
and position of long INDELs inside the basic A, B
groups. We identified the following subgroups:
A2, B2—subgroups of the A, B groups, respec-
tively, with long insertions. A2 remained empty, while
B2 contained 8 isolates with 29-nt insertions.
A3, B3—subgroups of the A, B groups, respec-
tively, with long deletions. A3 group consisted of 3-
isolate subgroup (LC2, LC3, and LC5) with a deletion
of length 386, Sin852 with a deletion of length 57, 2-
isolates subgroup (GZ-B and GZ-C) with a deletion
of length 39, Sin849 (deletion of length 49, embed-
ded), and Sin846 (137, overlapping). B3 subgroup
consisted of the isolates ZS-A (ZS-B) and ZS-C with
the deletion of length 53.
A4 and B4 were the subgroups with many individ-
ual INDELs (Table 1). The rests of the A, B groups
were denoted as A1 and B1, respectively.
It can be noted that proposed grouping of 96 iso-
lates, based on SNV and INDEL contents, conserved
the earlier classification T-T-T-T/C-G-C-C (38), and
partially coincided with the extension of this classifi-
cation (39,40). The four loci (9,404, 17,564, 22,222,
and 27,827), as the basis for this classification, fitted
nicely into our grouping (basically A1 group coincided
with T-T-T-T type, while B1 group coincided with
C-G-C-C type), expressing two inter-types: T-G-C-C
[isolates GZ50, HZS2-D, HZS2-E, HZS2-C, HGZ8L2,
HSZ2-A, NS-1(BJ04), HZS2-Fc, HZS2-Fb, and TJF]
and C-G-T-T (isolates ShanghaiQXC1 and Shang-
haiQXC2) (Figure 5). We found that another five loci,
which are among the most represented SNVs' loci (po-
sitions 3,852, 9,479, 11,493, 21,721, and 26,477; Fig-
ure 1), further refined our classification providing for
sub-classification of the basic types.
There were two basic nine-locus types:
TTTT/TTCGG and CGCC/TTCAT, mostly coin-
ciding with the A1, B1 groups, and the two inter-
groups: an inter-(A-B)-group had the inter-type
TGCC/TTCGT, and a subgroup of the group B1
(two Shanghai isolates) represented another inter-
type CGTT/TTCGT (Figure 5). The proposed ex-
tension to the two main sequence variants (TTTT,
CGCC) for an enlarged set of isolates, is in accordance
with the new insights into possible epidemiological
spread, both in space and time (36, 38, 41). Namely,
positions 3,852 and 11,493 differentiated between the
two subgroups of the group A1 (all of the TTTT
type): Taiwan epidemic (nucleotides C, T) from the
other late epidemic isolates (nucleotides T, C) (41),
i.e., isolates closer to a Hong Kong virus unrelated
to Hotel M (nucleotides C, T: isolates TW6-TW10,
Taiwan TC1-TC3), and the others from the Hotel
M lineage [nucleotides T, C: isolates from Canada
(Tor2), Singapore (all Sin's), Frankfurt (FRA Fr 1),
Taiwan (TW1-TW5), Hong Kong (HKU 39849), Italy
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Fig. 5 Three-level classification of 103 SARS-CoV genome isolates. Grouping of isolates is based on genome polymor-
phism, and classification is based on nine distinguished loci, mapped onto the bootstrapped phylogenetic tree obtained
using CLUSTAL X and Neighbor Joining method, and drawn using PhyloDraw programs. Bootstrapping is performed
with random number generated seed 111 and number of trials in bootstrap 1000. The two basic groups, A and B,
are represented in yellow and blue, respectively. Types obtained according to the nine genome loci (9,404, 17,564,
22,222, 27,827 / 3,852, 9,479, 11,493, 21,721, 26,477) are labeled along the left edge of the figure and have the form
NNNN / NNNNN, where N represents any nucleotide. Different subtypes are denoted by the corresponding substituted
nucleotides in red. Dotted lines distinguish between the three epidemiological phases.
(HSR 1), China (ZJ01), etc.] (36). Position 9,479
decomposed the B group [differentiated subgroup B1
(T) from the subgroups B2, B3 (C)], position 21,721
distinguished the group A from the group B. Precise
characterization based on the nine loci, for all the iso-
lates, is given in Table 1 and Figure 5.
As compared to genotype clustering of SARS-CoV
covering the epidemics from 2002 to 2004 (7,8), it
can be noticed that the grouping we proposed was at
most in accordance with it. Namely, the following cor-
respondence between the two grouping schemes may
be established:
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Firstly, genotype class CGCC/TCCAT (covering
B2 and B3 subgroups), corresponded to human pa-
tients' isolates from the early phase 2002-2003 (ZS,
HSZ, GD01, GZ02—Guangzhou, China), and palm
civet isolates (SZ3, SZ16—Hong Kong).
Secondly, genotype class TGCC/TTCGT,
TGCC/TTCAT (small part of A1 group), as well as
CGCC/TTCAT (B1 group), corresponded to human
patients middle phase 2002-2003 (positions 3,852,
9,479, 11,493, 26,477 determined this subclass); Bei-
jing (BJ01-BJ04), and Hong Kong (CUHK W1).
Thirdly, genotype classes TTTT/NNNNN,
CGTT/NNNNN (almost the entire A group and
Shanghai part of the B1 group) corresponded to
human patients late phase 2002-2003 (Figure 5)—
Singapore (Sin s), Taiwan (TW1-11), Shanghai (QX1,
QX2), Italy (HSR 1), Canada (Tor2), Hanoi (Urbani),
Hong Kong (HKU39849, CUHK-AG0x), China (ZJ01,
WHU, PUMC0x), Frankfurt (FRA, Frankfurt 1), etc.
The two basic groups, A and B, were rather con-
tiguously mapped onto the phylogenetic tree, show-
ing a high degree of accordance among the proposed
grouping and the phylogenetic relationships. Excep-
tions represented the two isolates of the B4 group,
with large number of SNVs and individual insertions
(ZMY 1, ZJ01), as well as the two isolates of the Bl
group (Shanghai QXC1 and QXC2), all of which be-
ing at large root-distances (Figure S10).
Materials and Methods
Dataset
Nucleotide sequences of 103 SARS-CoV complete
genomes were taken from the PubMed NCBI En-
trez database (http://www.ncbi.nlm.nih.gov/entrez)
in GenBank and FASTA formats. Since there were
7 pairs of nucleotide-identical isolates, we considered
the dataset to consist of 96 isolates (Tables 1 and
S1). All the sequences are between 29,013 (Shang-
haiQXC2) and 29,767 (Sin3408) in length. Out of all,
19 sequences have ambiguous nucleotide codes, i.e.,
N, M, R, Y, W, K, S (Table Si). Out of 96 isolates,
42 are fully or partially annotated. All the anno-
tated isolates have the S protein annotated of length.
3,768 and the N protein of length 1,269 nucleotides,
4 isolates do not have the E protein (CUHK-Su10,
PUMC01, PUMC02, PUMC03) of length 231 (except
for Sino1-11 of length 228 nucleotides), 1 isolate does
not have the M protein (CUHK-Su10) of length 666
nucleotides. Out of 42 annotated isolates, 13 have 5'
UTR and 12 have 3' UTR determined. All the iso-
lates are human sourced except for two isolated from
palm civet (Paguma larvata), SZ3 and SZ16-
Genome polymorphism
The CLUSTAL X program, version 1.83 (42) has been
applied to all the isolates from the dataset. The over-
all CLUSTAL X output had length of 29,903 nt. Then
5' UTR and 3' UTR were identified based on positions
in annotated isolates. Coding region encompassed the
interval (301, 29,528), and had the length of 29,228 nt.
We developed a program in Perl language for anal-
ysis of a CLUSTAL X output. The program first
calculated an "average" isolate, the so called "pro-
file" , by counting, for each position in the CLUSTAL
X output, the number of occurrences of each differ-
ent letter (including dash), and by choosing the most
represented one; positions containing dashes in the
"profile" are called "empty positions", all the others
being "non-empty" ones. The program then counted
SNVs, INDELs, and calculated their absolute and rel-
ative positions, for every isolate with respect to the
"profile", and for different genome regions (ORFs, 5'
UTR, 3' UTR, and IGRs).
Substitution rate for the SARS-CoV genome and
for the S protein for all the sequences in the dataset
was calculated by dividing the total number of SNV
sites by the length of the corresponding nucleotide se-
quence; non-synonymous substitution rate for the S
protein was calculated by dividing the total number
of non-synonymous SNV sites by the length of the S
protein.
Entropy of sites
The entropy of each site has been calculated based on
number of SNVs at that site, in order to estimate the
sites' conserveness. If we denote by p(b)—probability
of occurrence of the nucleotide b (b being A, C, G, or
T), and under assumption of sites being independent,
we calculated the entropy of positions by the follow-
ing formula (43): E = - sum p(6)* log[p(6)] (sum
over b). In this definition, p(b)* log[p(6)] is taken to
be zero if p(6) = 0.
Phylogenetic investigations
The first type of classification was performed the same
way as in Pavlovic-Lazetic et al (37). It is based on
genome polymorphism (SNVs and INDELs). The dis-
tribution of isolates per SNV numbers (outside 5', 3'
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UTRs) was analyzed and the isolates were primar-
ily classified into two groups—isolates with "small"
number of SNVs and isolates with "large" number of
SNVs. The isolates "close to border" were further
tested (on the number of SNVs) against the profile
isolates of each of the two groups, resulting in some
isolates changing the group. A sub-classification was
then performed on the presence of long or short IN-
DELs inside each of the two groups.
The second type of classification was performed
based on contents of the most represented SNV sites.
Except for earlier identified positions (9,404, 17,564,
22,222, 27,827) classifying isolates into TTTT/CGCC
genotypes (38,39), some other positions (geno-
types) were identified as potential bases for sub-
classification.
In order to compare the two classification schemes
developed, with the existing programming systems for
phylogenetic analysis, phylogenetic bootstrapped tree
was produced using CLUSTAL X program and the
Neighbor Joining (NJ) method. The NJ method, as
well as parsimony and the probabilistic models, pro-
duces unrooted trees. In order to produce the con-
sensus tree, bootstrapping is performed with random
number generated seed 111 and number of trials in
bootstrap 1000. The tree is drawn using the Phylo-
Draw program (44) and the proposed classification
schemes were mapped onto it.
Annotation and analysis of the S pro-
tein
All the S protein sequences (those extracted from
annotated isolates and the others we annotated us-
ing the publicly available program from PubMed
tools for data mining; http://www.ncbi.nlm.nih.gov/
gorf/gorf.html) have been aligned using CLUSTAL X
program. Then the S protein was analyzed using the
same methods as for the complete isolates.
Mutation analysis of the S protein
Non-synonymous nucleotide substitution per non-
synonymous site (Ka) and synonymous nucleotide
substitution per synonymous site (Ks) were calcu-
lated using the DnaSP 4.0 program (45). It is
based on a method defined by Nei and Gojovori (46)
that estimates the numbers of synonymous and non-
synonymous nucleotide substitutions between two
DNA sequences by counting the number of such sub-
stitutions in the corresponding pairs of codons. It also
takes into account different evolutionary pathways be-
tween pairs of codons. The DnaSP program may run
with or without an outgroup. The ratio Ka/Ks is con-
sidered as a selection parameter (Ka/Ks > 1 is usually
interpreted as an indicator of positive selection). The
coefficients Ka, Ks, as well as the ratio Ka/Ks were
calculated first for the S protein in all the isolates in
the dataset, without an outgroup. Since among the
91 isolates there were 89 human patients' isolates and
2 palm civet isolates (SZ3, SZ16), we then calculated
the Ka and Ks coefficients and the ratio Ka/Ks for
the 89 human patients' isolates only, without an out-
group, too. Eventually, we ran the program for all the
human patients' isolates and each of the palm civet
isolates as the outgroup, in order to test the hypothe-
sis that the S gene was subjected to positive selection
during virus transmission from animals to humans.
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